Senior Compliance Manager - ANZ at Gilead Sciences

Melbourne, Victoria, Australia

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, PharmaceuticalIndustries

Requirements

Experience in healthcare compliance monitoring, risk assessment, and third-party due diligence
Knowledge of relevant laws and the Medicines Australia Code of Conduct
Familiarity with Gilead’s Healthcare Compliance Policies and Processes
Ability to leverage data analytics and risk-based sampling
Skills in leading risk assessments, training, discussions, investigations, and complaints
Capability to collaborate with cross-functional teams (e.g., IT, Commercial, Development, Medical Affairs, Public Affairs, Government Affairs, Finance, Clinical)
Based in Melbourne, Australia

Responsibilities

Support the monitoring, risk assessment, and third-party due diligence teams in compliance activities
Support the team to develop and align on a multi-faceted healthcare compliance monitoring and risk assessment strategy
Drive the timely development and propagation of ongoing enhancements to the company’s healthcare compliance monitoring and risk assessment program
Collaborate with the team to ensure timely and appropriate action is taken to address potential risks and identified issues
Partner with various business functions to explore ways in which monitoring and risk assessment related data may be used to support business strategy and objectives in a compliant manner
Support various business functions in designing business-led monitoring approaches
Work closely with colleagues across different functions to leverage information from relevant systems for identification and addressing of potential compliance-related issues
Help drive innovation and consistency in compliance-related monitoring, risk assessment, and due diligence, ensuring Gilead and industry best practices are shared and adopted across functions

Skills

Healthcare Compliance

Compliance Monitoring

Risk Assessment

Third-Party Due Diligence

Regulatory Compliance

Pharmaceutical Compliance

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free